What is Canopus Biopharma, Inc. (CBIA) stock price today?

Canopus Biopharma, Inc. (CBIA) is currently trading at $0.00.

What is CBIA P/E ratio?

Canopus Biopharma, Inc.'s P/E ratio is -0.01. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is Canopus Biopharma, Inc.'s market cap?

Canopus Biopharma, Inc. has a market capitalization of $455071.

OTC · Medical - Pharmaceuticals

Canopus Biopharma, Inc. (CBIA) Stock

$0.00 OTC: CBIA Healthcare

Canopus Biopharma, Inc. engages in the acquisition of businesses.

Valuation

Metric	Value
Price	$0.00
Market Cap	$455071
P/E Ratio	-0.01
P/B Ratio	-0.83
P/S Ratio	0.00
EPS (TTM)	$-0.01
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	—
ROA	—
ROCE	—
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	-0.77
Current Ratio	0.24

Annual Financials (USD)

Metric	2012	2013	2021	2022
Revenue	$0	$0	$0	$0
Operating Profit	$0	$-1.0M	$0	$-1.0M
Net Profit	$-1.0M	$-1.0M	$0	$-1.0M
EPS	$-0.02	$-0.02	$0.00	$-0.01
Op Margin	—	—	—	—

Balance Sheet (USD)

Metric	2012	2013	2021	2022
Total Assets	$2.0M	$2.0M	$0	$0
Total Liabilities	$4.0M	$2.0M	$0	$0
Cash	$0	$0	$0	$0
Borrowings	$4.0M	$2.0M	$0	$0

Cash Flow (USD)

Metric	2012	2013	2021	2022
Operating Cash Flow	$-1.0M	$2.0M	$0	$0
Investing Cash Flow	$0	$-2.0M	$0	$0
Financing Cash Flow	$0	$0	$0	$0
Net Cash Flow	$0	$0	$0	$0
Free Cash Flow	$-1.0M	$2.0M	$0	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.60
FCF Yield	-1.36%
Quick Ratio	0.24
Interest Coverage	-5272.83
Return 1Y	900.00%
Return 3Y	-95.83%
Return 5Y	-99.88%

Ownership

Insiders Held65.52%

Institutions Held0.00%

Institutions Float Held0.00%

Institutional Holder	Shares	Report Date
Hollencrest Capital Management	80,000	2022-09-30

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AGINAmerican Graphite Technologies, Inc.	$0.00	—	9.50	$182558	0.00%
APHDApogee 21 Holdings, Inc.	$1.70	+0.00%	-15.90	$722510	0.00%
CCWFChurch & Crawford, Inc.	$0.00	—	—	$1.42M	0.00%
CHIFChina Food and Beverage Company	$0.00	—	0.00	$2326	0.00%
FBDSFuss Brands Corp	$0.10	+0.00%	-16.83	$2.17M	0.00%

About Canopus Biopharma, Inc.

Canopus Biopharma, Inc. engages in the acquisition of businesses. The company was founded on April 8, 1986 and is headquartered in Las Vegas, NV.

Canopus Biopharma, Inc. (CBIA) stock trades at $0.00 with a market capitalization of $455071. The stock is valued at a price-to-earnings (P/E) ratio of -0.01, price-to-book of -0.83, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Canopus Biopharma, Inc. generates an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.blueheaven.cafe